IndieBio is the world's leading seed-stage life science accelerator program devoted to funding and building startups dedicated to solving humanity’s most pressing problems through biology. To date, 81 companies have graduated from the program, with a combined current valuation of over $500M.
Startup accelerator for life sciences. IndieBio is a member of SOSV, a global fund with $300M assets under management.
—Information provided by company